Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-18

FDA Approved: PROZAC — Supplemental Application (Dista Products Company)

View source ↗

Summary

FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prozac (Fluoxetine)

Snippet

SUPPL AP for PROZAC (FLUOXETINE HYDROCHLORIDE)